<?xml version="1.0" encoding="UTF-8"?>
<mods xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.loc.gov/mods/v3" version="3.1" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd">
  <titleInfo>
    <title>Peptide drug discovery and development : translational research in academia and industry</title>
  </titleInfo>
  <name type="personal">
    <namePart>Castanho, Miguel A. R. B.</namePart>
  </name>
  <name type="personal">
    <namePart>Santos, Nuno.</namePart>
  </name>
  <name type="corporate">
    <namePart>Wiley InterScience (Online service)</namePart>
  </name>
  <typeOfResource>text</typeOfResource>
  <genre authority="marc">bibliography</genre>
  <genre authority="">Electronic books.</genre>
  <genre authority="fast">Case studies.</genre>
  <genre authority="local">Electronic books.</genre>
  <originInfo>
    <place>
      <placeTerm type="code" authority="marccountry">gw</placeTerm>
    </place>
    <place>
      <placeTerm type="text">Weinheim</placeTerm>
    </place>
    <publisher>Wiley-VCH</publisher>
    <dateIssued>©2011</dateIssued>
    <dateIssued encoding="marc">2011</dateIssued>
    <issuance>monographic</issuance>
  </originInfo>
  <language>
    <languageTerm authority="iso639-2b" type="code">eng</languageTerm>
  </language>
  <physicalDescription>
    <form authority="gmd">electronic resource</form>
    <extent>1 online resource (xix, 370 pages) : illustrations</extent>
  </physicalDescription>
  <tableOfContents>Front Matter -- The Academia-Market Bouncing of Peptide Drugs : Challenges and Strategies in Translational Research with Peptide Drugs. Peptides as Leads for Drug Discovery / Paul J Edwards, Steven R LaPlante -- Marketing Antimicrobial Peptides: A Critical Academic Point of View / Eduard Bardaj̕ -- Oral Peptide Drug Delivery: Strategies to Overcome Challenges / Josias H Hamman, Jan H Steenekamp -- Rational Design of Amphipathic a-Helical and Cyclic [beta]- Sheet Antimicrobial Peptides: Specificity and Therapeutic Potential / Wendy J Hartsock, Robert S Hodges -- Conotoxin-Based Leads in Drug Design / Muharrem Akcan, David J Craik -- Plant Antimicrobial Peptides: From Basic Structures to Applied Research / Suzana M Ribeiro, Simoni C Dias, Octavio L Franco -- Peptide Drugs' Translational Tales : Peptide Drugs before, Through and after Industry Pipelines. Omiganan Pentahydrochloride: A Novel, Broad-Spectrum Antimicrobial Peptide for Topical Use / Evelina Rubinchik, Dominique Dugourd -- Turning Endogenous Peptides into New Analgesics: The Example of Kyotorphin Derivatives / Marta M B Ribeiro, Isa D Serrano, S̤nia S̀ Santos -- The Development of Romiplostim : A Therapeutic Peptibody Used to Stimulate Platelet Production / Graham Molineux, Ping Wei -- HIV vs. HIV: Turning HIV-Derived Peptides into Drugs / Henri G Franquelim, Pedro M Matos, A Salom̌ Veiga -- Sifuvirtide, A Novel HIV-1 Fusion Inhibitor / Xiaobin Zhang, Hao Wu, Fengshan Wang -- Whither Peptide Drugs? Peptides Shaping the Future of Drug Development. Endogenous Peptides and Their Receptors as Drug Discovery Targets for the Treatment of Metabolic Disease / Mary Ann Pelleymounter, Yuren Wang, Ning Lee -- Translation of Motilin and Ghrelin Receptor Agonists into Drugs for Gastrointestinal Disorders / Gareth J Sanger, John Broad, David H Alpers -- Of Mice and Men: Translational Research on Amylin Agonism / Jonathan D Roth, Christine M Mack, James L Trevaskis, David G Parkes -- Peptides and Polypeptides as Immunomodulators and Their Consequential Therapeutic Effect in Multiple Sclerosis and Other Autoimmune Diseases / Ruth Arnon, Michael Sela, Rina Aharoni -- Development of Antibody Fragments for Therapeutic Applications / Sofia Carte-Real, Frederico Aires da Silva, Joao Gonzalves -- Index.</tableOfContents>
  <note type="statement of responsibility">edited by Miguel Castanho and Nuno C. Santos.</note>
  <note>Includes bibliographical references and index.</note>
  <subject authority="lcsh">
    <topic>Peptide drugs</topic>
  </subject>
  <subject authority="lcsh">
    <topic>Peptide drugs</topic>
    <topic>Case studies</topic>
  </subject>
  <subject authority="lcsh">
    <topic>Drug development</topic>
  </subject>
  <subject authority="bisacsh">
    <topic>MEDICAL</topic>
    <topic>Pharmacology</topic>
  </subject>
  <subject authority="fast">
    <topic>Drug development</topic>
  </subject>
  <subject authority="fast">
    <topic>Peptide drugs</topic>
  </subject>
  <classification authority="lcc">RS431.P38 P47 2011</classification>
  <classification authority="ddc" edition="22">615.3</classification>
  <relatedItem type="otherFormat" displayLabel="Print version:">
    <titleInfo>
      <title>Peptide drug discovery and development</title>
    </titleInfo>
    <originInfo>
      <publisher>Weinheim : Wiley-VCH, ©2011</publisher>
    </originInfo>
    <identifier type="local">(OCoLC)751833775</identifier>
  </relatedItem>
  <identifier type="isbn">9783527636730</identifier>
  <identifier type="isbn">3527636730</identifier>
  <identifier type="isbn">9783527636754</identifier>
  <identifier type="isbn">3527636757</identifier>
  <identifier type="isbn" invalid="yes"/>
  <identifier type="isbn" invalid="yes"/>
  <identifier type="isbn" invalid="yes"/>
  <identifier type="isbn" invalid="yes"/>
  <identifier type="stock number">10.1002/9783527636730 Wiley InterScience</identifier>
  <identifier type="uri">http://onlinelibrary.wiley.com/book/10.1002/9783527636730</identifier>
  <location>
    <url>http://onlinelibrary.wiley.com/book/10.1002/9783527636730</url>
  </location>
  <recordInfo>
    <recordContentSource authority="marcorg">DG1</recordContentSource>
    <recordCreationDate encoding="marc">111117</recordCreationDate>
    <recordChangeDate encoding="iso8601">20171116091816.0</recordChangeDate>
    <recordIdentifier source="OCoLC">ocn761319845</recordIdentifier>
    <languageOfCataloging>
      <languageTerm authority="iso639-2b" type="code">eng</languageTerm>
    </languageOfCataloging>
  </recordInfo>
</mods>
